Mon-Fri 8-16 (GMT +2)
Chief Physician, Nuclear Medicine
Specialist in Clinical Physiology and Nuclear Medicine
M.D., Ph.D., Adj. Prof.
PET-CT and SPECT-CT imaging, cancers, especially prostate cancer. Additionally, inflammation imaging and endocrinological, neurological and cardiological imaging.
Interpretation of isotope and PET images: e.g. cancer staging, assessment of response to therapy, verification of disease recurrence, imaging in preparation of radiotherapy and locating the unknown primary tumor. Also, isotope treatments and their follow-up.
Jukka Kemppainen's recent research has focused on the clinical applications of PET imaging in disease diagnostics. His main interests reside in the development of new PET imaging tracers for prostate cancer and PET diagnostics.
Finnish Society of Nuclear Medicine, Chairman
Scandinavian Society of Clinical Physiology and Nuclear Medicine (SSCPNM), Finnish Representative